However, results failed to reach statistical significance due to the large sample-to-sample variability within the ALS group.
← all excerpts
Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis.
1
—
—